# Piper Sandler

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/piper-sandler
Canonical HTML page: https://getyourbrief.com/entity/piper-sandler

## Timeline

- **2026-08-21**: Insider Filings Publicized; Shares Fall 3% — Form 4 filing disclosed; MRCY shares trade down $2.87 midday to $91.36 on 1.12M shares vs average 675,344.
- **2026-08-20**: Farnsworth Sells $645,794.04 in MRCY Stock — EVP David Farnsworth sells 6,612 shares at average $97.67, reducing direct ownership by 5.31% to 117,967 shares.
- **2026-08-18**: MRCY Reports Mixed Q4; Ratner Sells Shares — Mercury Systems posts EPS of $0.37 vs $0.38 consensus and revenue of $289.78M vs $266.09M. EVP Steven Ratner sells 1,971 shares at $111.36 for $219,490.56 to cover tax withholding.
- **2026-07-22**: Quarterly earnings released — SMBC reports EPS of $1.83 vs. $1.52 estimate, revenue of $51.77M.
- **2026-07-08**: Wells Fargo Cuts Target to $70 — Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside.
- **2026-07-01**: Stephens reiterates Overweight rating — Stephens restated its Overweight rating and $40 price target, implying 8.78% upside.
- **2026-07-01**: Bank of America Lowers Target — Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating.
- **2026-06-26**: Piper Sandler adjusts PT — Piper Sandler reiterates Neutral, boosts target from $71 to $79.
- **2026-06-15**: Piper Sandler Stays Overweight — Piper Sandler reaffirms an Overweight rating on Freshpet shares.
- **2026-06-06**: Wall Street Zen upgrades to Hold — Wall Street Zen upgraded PZZA from Sell to Hold.
- **2026-06-05**: Insider sale by EVP Windes — EVP Richard Windes sells 2,000 shares at average $69.70, totaling $139,400.
- **2026-06-04**: Weiss Ratings reiterates Buy — Weiss Ratings issues a 'buy (b)' rating on SMBC.
- **2026-06-01**: Weiss Ratings Downgrades — Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'.
- **2026-05-18**: Weiss Ratings downgrades to Sell — Weiss Ratings downgraded Papa John's from Hold (c-) to Sell (d+).
- **2026-05-11**: Mizuho lowers target to $33 — Mizuho reduced its price objective from $34 to $33, rating the stock Neutral.

## Recent coverage (15 stories, network-wide)

### Mercury Systems EVP Sells $645K Stock as EPS Misses by $0.01
2026-08-22 15:35:00 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Two Mercury Systems EVPs disclosed sell-to-cover trades totaling about $865K after an EPS miss of $0.01 and revenue beat. The transactions were driven by tax withholding on vested awards, but the stock's slide below moving averages adds pressure. Investors should separate mechanical insider flows from fundamental margin challenges.
Full story: https://getfinancebrief.com/story/mercury-systems-insider-selling-645k-eps-miss

### Mill Capital Buys $1.09M Chubb Stake as Analysts Push Targets to $386
2026-08-16 01:05:50 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Institutional 13F data shows new accumulation in Chubb as small advisory firms added positions from Q4 2025 through Q2 2026. Analyst targets range from $301 to $386, while insider sales and 83.81% institutional ownership frame a mixed but liquid market for CB.
Full story: https://getfinancebrief.com/story/mill-capital-chubb-13f-finance-2026

### Wells Fargo Slashes CHKP Target to $130: 13.01 P/E and Consensus Hold Demand Attention
2026-08-12 13:16:01 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wells Fargo lowered Check Point's target to $130, highlighting a divided analyst community with an average target of $149.48. The stock's depressed valuation and low beta present a potential value opportunity against high-growth cyber peers.
Full story: https://getfinancebrief.com/story/chkp-price-target-130-finance-analysis

### Benchmark Raises Price Targets: INBK +6% to $35, DXCM +6.5% to $82
2026-08-12 13:01:32 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Benchmark boosted outlooks on two disparate stocks—First Internet Bancorp and DexCom—offering a stark contrast in risk/reward. While INBK promises 21.74% upside based on the new $35 target, DXCM’s $82 target sits slightly below its trading price, highlighting valuation concerns despite a Buy rating.
Full story: https://getfinancebrief.com/story/benchmark-raises-inbk-dxcm-july-2026

### Collegium Pharma EPS Beats by $0.20; Revenue Grows 6.3% to $199.88M
2026-08-09 18:29:04 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Collegium Pharmaceutical's Q2 2026 earnings beat signals sustained demand for its abuse-deterrent pain medications. Revenue grew 6.3% to $199.88M, and EPS of $1.92 surpassed forecasts by $0.20, indicating commercial strength despite regulatory pressures.
Full story: https://gethealthbrief.com/story/collegium-pharma-q2-2026-earnings-health

### COLL Beats Q2 EPS by $0.20, Stock Gains 1.24% to $29.47
2026-08-09 18:28:55 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Collegium Pharmaceutical delivered an 11.6% EPS beat and modest revenue beat, lifting shares to $29.47. High ROE and institutional accumulation offset by high leverage and mixed analyst ratings create a nuanced investment case.
Full story: https://getfinancebrief.com/story/collegium-pharma-q2-2026-earnings-finance

### COLL Q2 EPS Beats by $0.20; Revenue Up 6.3% to $199.88M
2026-08-09 18:28:47 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Collegium Pharmaceutical's earnings beat of $0.20 per share, reaching $1.92 on $199.88M revenue, highlights its commercial success in the abuse-deterrent opioid space, a key sector for the biopharma industry.
Full story: https://getbiobrief.com/story/collegium-pharma-q2-2026-earnings-bio

### SMBC Beats EPS by $0.31, Stock Down 1.4% Amid Insider Selling
2026-07-23 00:54:41 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Southern Missouri Bancorp delivered a strong quarter with earnings of $1.83 per share, beating estimates by $0.31 on revenue of $51.77 million. However, the stock fell 1.4% to $75.41 as analysts remain divided and insider selling raises questions.
Full story: https://getfinancebrief.com/story/smbc-earnings-beat-stock-down-insider-sell

### WaFd Misses EPS by $0.02, Stock Near $39.49 High: Buy the Dip or Take Profits?
2026-07-17 04:04:47 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

WaFd (WAFD) reported quarterly EPS of $0.81, missing consensus by 2.4%, while the stock trades near a 52-week high and offers a 2.7% dividend yield. Analysts are split between hold and buy, and an insider sale adds caution. For income-focused investors, the small miss may be overshadowed by the stable payout and institutional accumulation.
Full story: https://getfinancebrief.com/story/wafd-earnings-miss-eps-dividend-finance-analysis

### Coinbase Trading Volumes to Drop 44% in 2026—But Bitcoin Bottom Could Spark 32% Rebound
2026-07-16 15:46:27 · Sector: crypto · Sentiment: Positive · Impact: 6/10 · Sources: 2

Coinbase’s total trading volume is forecast to plunge 44% to $669 billion in 2026, yet analysts at William Blair see a sharp recovery in 2027 as Bitcoin stabilizes. The exchange’s push into Base layer-2, perpetual futures, and prediction markets adds new revenue drivers for the next cycle.
Full story: https://getcryptobrief.com/story/coinbase-volumes-drop-bitcoin-rebound

### Coinbase Jumps 4% After EBITDA Forecast Slashed 34%—Why Analysts Aren't Panicking
2026-07-16 15:45:47 · Sector: finance · Sentiment: Positive · Impact: 6/10 · Sources: 2

Despite a 34% cut to adjusted EBITDA estimates, Coinbase stock rallied on an Outperform rating from William Blair, signaling that the worst may be priced in. The firm expects a 44% drop in 2026 trading volumes before a rebound, while Piper Sandler lowered its target but remained neutral.
Full story: https://getfinancebrief.com/story/coinbase-stock-gains-despite-earnings-cut

### Wells Fargo Cuts Freshpet Target to $70, Still Sees 28% Upside
2026-07-09 13:12:08 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wells Fargo lowered its price target on Freshpet to $70 from $75 while maintaining an Overweight rating, implying the stock is undervalued by 28%. The market remains skeptical with FRPT trading at $54.51, well below the consensus analyst target of $74.25. Analysts overall rate the pet food company a Moderate Buy, despite a string of recent target cuts.
Full story: https://getfinancebrief.com/story/wells-fargo-cuts-freshpet-target-70-upside

### Papa John's Overweight Call Sees 8.78% Upside—What It Means for QSR Retailers
2026-07-06 01:54:29 · Sector: retail · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Stephens reiterated an Overweight rating on Papa John's with a $40 target, signaling an 8.78% upside. The Hold consensus and mixed analyst views reflect retail headwinds for the pizza chain amid fierce QSR competition and shifting consumer spending.
Full story: https://getretailbrief.com/story/papa-johns-overweight-rating-8-78-upside-retail

### Toast’s SaaS Platform Gets Overweight Rating: $32 Price Target on Cloud Growth
2026-06-22 09:33:27 · Sector: saas · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Piper Sandler initiated Toast with an Overweight rating and a $32 price target, highlighting the company's cloud-based restaurant management platform. The 29% upside reflects confidence in its modular SaaS model and growing ecosystem of integration partners like Cartwheel and Stream.
Full story: https://getsaasbrief.com/story/toast-saas-overweight-rating-cloud-growth

### Toast Stock: 29% Upside as Piper Sandler Sees ‘Room to Run’ in 500-Location Deal
2026-06-22 09:33:19 · Sector: retail · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Piper Sandler launched coverage on Toast with an Overweight rating and $32 price target, citing the company’s enterprise deal with Hungry Howie’s and new market expansion. The cloud platform supports over 500 locations, signaling strong retail adoption and 29% upside potential.
Full story: https://getretailbrief.com/story/toast-overweight-rating-retail-tech-500-deal

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.